Focus on these 4 pharma stocks: Sun Pharma, Zydus, Alembi, Rubicon on Monday
Summary
Explore key updates on Sun Pharma's major acquisition, Zydus' malaria trials, Alembic's FDA approval, and Rubicon's inspection
Description
Explore key updates on Sun Pharma's major acquisition, Zydus' malaria trials, Alembic's FDA approval, and Rubicon's inspection
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source